Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
Open Access
- 2 November 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 15, 309-317
Abstract
Background: In the absence of direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option for cytokine removal. Objective: This study aimed to describe and compare cytokine removal during intermittent haemodialysis (IHD) and continuous renal replacement therapy (CRRT) in COVID-19 patients with Acute Kidney Injury (AKI). Methods: It was a cohort study that studied patients with COVID-19-related AKI according to KDIGO criteria and admitted at Intensive Care Unit (ICU). Blood samples were collected at the start and end of both IHD using high flux (HF) membranes (10 patients) and continuous venovenous haemodiafiltration (CVVHDF:10 patients) in two sessions for measuring 13 different plasma interleukins and calculating the cytokine removal rate. Results: There was no difference between the two groups regarding mechanical ventilation, vasoactive drug, age or prognostic scores. Patients treated by CRRT presented higher levels of IL-2 and IL-8 than patients treated by IHD at dialysis start. Cytokine removal ranged from 9% to 78%. Patients treated by CRRT presented higher cytokine removal for IL-2, IL-6 IL-8, IP-10 and TNF. The removal rates of IL-4, IL-10, IL-17A, IFN, MCP-1 and TGF-B1 were similar in two groups. After one session of CVVHDF (24 h), IL-2 and IL-1β levels did not vary significantly, whereas IL-4, IL-6, IL-8, IL-10, IL-17A, TNF, IFN, IP-10, MCP-1, IL-12p70 and TGF-B1 decreased by 33.8– 76%, and this decrease was maintained over the next 24 h. In IHD groups, IL-2, IL-6, TNF, IP-10 and IL-1β levels did not decrease significantly whereas IL-4, IL-8, IL-10, IL-17A, IFN, MCP-1, IL-12p70 and TGF-B1 decreased by 21.8– 72%; however, cytokine levels returned to their initial values after 24 h. Conclusion: Cytokine removal is lower in IHD using HF membranes than in CVVHDF, and in IHD the removal is transient and selective, which can be associated with mortality during cytokines storm-related COVID-19.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- Dialysis Complications in Acute Kidney Injury Patients Treated With Prolonged Intermittent Renal Replacement Therapy Sessions Lasting 10 Versus 6 Hours: Results of a Randomized Clinical TrialArtificial Organs, 2015
- Cytokine Removal with High Cut-Off Membrane: Review of LiteratureBlood Purification, 2014
- Extended Daily Dialysis in Acute Kidney Injury Patients: Metabolic and Fluid Control and Risk Factors for DeathPLOS ONE, 2013
- Hémodialyse continue avec membrane super high-flux au cours d’un choc septique : application cliniqueNephrologie & Therapeutique, 2013
- [The treatment of septic shock with continuous venovenous hemodialysis using high cut-off dialyzer in patient after immediate circulatory arrest].2013
- The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injuryBMC Nephrology, 2010
- Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failureCritical Care, 2010
- Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapyNephrology Dialysis Transplantation, 2004
- Extracorporeal Therapies in Non-Renal Disease: Treatment of Sepsis and the Peak Concentration HypothesisBlood Purification, 2004
- Rapid infusion of sodium bicarbonate and albumin into high-risk premature infants soon after birth: A controlled, prospective trialAmerican Journal of Obstetrics and Gynecology, 1976